Activity value 76philippines Buyer,Last transaction date:
2026-02-19
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for philgen pharmaceuticals inc. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 76 transactions, with a transaction quantity of 1540203.51 and a transaction weight of 71638.55.
YearTransactionsQuantityWeight
20256278330084.47784941.05
2026761540203.5171638.55
Bill of lading data
<
1/15
>
Trade date
2026/02/19
B/L No.
1333447
Suppliers
centurion laboratories
Buyers
philgen pharmaceuticals inc.
philgen pharmaceuticals inc. is philippines Buyer,
and primarily engages in the import and export business of products such as mg tablet,tablet,medicine.
According to the 52wmb.com global trade database, as of 2026-02-19, the company has completed 2333 international trades,
with its main trading regions covering india,philippines,china etc.
The core products include HS30049099000,HS30049079,HS30049099 etc,
often transported via manila,port manila international container terminal, port manila north harbor etc,
and its main trading partners are centurion laboratories,hebei jiheng pharmaceutical co,reyoung pharmaceuticals co.ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on philgen pharmaceuticals inc. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.